IDEXX Laboratories Earnings
NASDAQ: IDXXHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Mon, Nov 2, 2026
Before market open
Fiscal period
Sep/2026
EPS estimate
$3.70
IDEXX Laboratories earnings summary
IDEXX Laboratories is scheduled to report Sep/2026 earnings on Nov 2, 2026 before the market opens, with analysts expecting EPS of $3.70. In its most recent report on Aug 4, 2026 (Q2 2026), IDXX posted EPS of $4.27. Revenue for the quarter was $1.22 billion.
Quarterly EPS is up 17.6% from the same quarter a year earlier. Across the last 16 reports, IDXX shares moved an average of 4.0% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
IDXX earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 4, 2026 | — | $4.27 | — | -6.1% |
| May 5, 2026 | — | $3.47 | — | -5.6% |
| Feb 20, 2026 | — | $3.09 | — | +3.3% |
| Nov 3, 2025 | — | $3.40 | — | -2.6% |
| Aug 4, 2025 | — | $3.63 | — | -1.1% |
| May 1, 2025 | — | $2.96 | — | +4.2% |
| Feb 21, 2025 | — | $2.62 | — | -3.5% |
| Oct 31, 2024 | — | $2.80 | — | +3.8% |
| Aug 6, 2024 | — | $2.44 | — | +2.0% |
| May 1, 2024 | — | $2.81 | — | +6.1% |
| Feb 22, 2024 | — | $2.31 | — | +0.1% |
| Nov 1, 2023 | — | $2.53 | — | -0.1% |
| Aug 1, 2023 | — | $2.67 | — | +0.3% |
| May 2, 2023 | — | $2.55 | — | -0.2% |
| Feb 16, 2023 | — | $2.05 | — | -5.7% |
| Nov 1, 2022 | — | $2.15 | — | +18.7% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.